Resistin is a cysteine-rich hormone mainly secreted by adipose tissues and may form a biochemical link between obesity and type 2 diabetes. A research article published on January 7, 2008 in the World Journal of Gastroenterology (volume 14, issue 1) addresses these questions. Join discussion...

Deaths from cardiovascular disease are declining among men with diabetes, but not women, and poorer control of blood pressure and cholesterol levels may be to blame, a new study suggests. Join discussion...

MicroIslet is engaged in the research, development, and commercialization of patented technologies in the field of transplantation therapy for patients with insulin-dependent diabetes. MicroIslet believes its porcine xenotransplantation and proprietary technology may overcome many of the obstacles that have plagued islet cell transplantation Join discussion...

The researchers indicated that the T-cells that regulate the immune system lose their effectiveness over time, leading to type 1 diabetes . These ‘lazy’ cells are therefore the root cause of the disease, and could open up new treatment pathways in the future. Join discussion...

The investigational drug alogliptin alone is a safe and effective treatment for poorly controlled type 2 diabetes, according to study findings reported in the journal Diabetes Care. Alogliptin has been shown to reduce blood sugar levels after meals in patients with type 2 diabetes, Dr. Ralph A. DeFronzo at the University of Texas Health Science Center at San Antonio and colleagues note. Join discussion...

In a set of mouse experiments, scientists attempt to learn more about why sulfonylureas eventually fail in the treatment of patients with type 2 diabetes. They may be more likely to keep working if they are used in moderation and stopped for a period of time. Join discussion...

The application processes to the national regulatory agencies and ethics committees have proceeded according to plan, and the company has now received agency approvals for a European Phase III study of children and adolescents with type 1 diabetes in the Netherlands, United Kingdom, Finland, Slovenia, Spain and Sweden. Join discussion...

Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco. The drugs – imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent) – were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently in 80 percent of those that go into remission. Join discussion...

Gene tests may be no better for predicting diabetes risk than having a doctor ask some old-fashioned questions about weight, smoking status and family history, according to two studies published on Wednesday. Both studies published in the New England Journal of Medicine looked at more than 16 genes linked to type 2 diabetes and found that the information they provided was no better than traditional risk factors, including blood sugar levels. Join discussion...

Hiromu Sakurai and colleagues from the Suzuka University of Medical Science gave the drug based on vanadium and allaxin -- a compound found in garlic -- orally to type I diabetic mice. The researchers said they found it reduced blood glucose levels. Join discussion...